CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Coded Growth Innovation Center Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Coded Growth Innovation Center Inc
375 N Stephanie St, Suite 1411
Phone: (647) 426-1640p:647 426-1640 HENDERSON, NV  89014  United States Ticker: DMSIDMSI

This company ceased filing statements with the SEC on 7/29/2010.

Business Summary
Coded Growth Innovation Center, Inc., formerly Dermisonics, Inc., is a development stage company. The Company’s principal activity is to provide drugs delivery system. Its Transdermal systems deliver drugs through the skin into the bloodstream. Medications delivered via skin patches avoid liver metabolism, a necessary feature for drug molecules to metabolize easily, and allows for lower dosing of medications. There are two types of transdermal delivery systems: passive and active. In passive transdermal systems, the drug diffuses through the skin where it can act locally or penetrate the capillaries for systemic effect. Active patches require a physical force to facilitate the movement of drug molecules across the skin. It is a development stage company.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20079/30/2006YesYes---

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, Interim Chief Executive Officer, Interim Chief Financial Officer Bruce H.Haglund 60 8/6/2004 8/6/2004
Director Grant R.Atkins 48 3/1/2006 3/1/2006
Director Bruce K.Redding 62 1/1/2004 1/1/2004

Business Names
Business Name
Dermisonics, Inc
DMSI
SECOND STAGE VENTURES INC

General Information
Outstanding Shares: 63,909,005 (As of 9/30/2010)
Shareholders: 100
Stock Exchange: OTC
Federal Tax Id: 980233859


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, August 29, 2023